Ethan J. Rowin

10.3k total citations · 2 hit papers
170 papers, 5.3k citations indexed

About

Ethan J. Rowin is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Ethan J. Rowin has authored 170 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Cardiology and Cardiovascular Medicine, 31 papers in Epidemiology and 25 papers in Surgery. Recurrent topics in Ethan J. Rowin's work include Cardiomyopathy and Myosin Studies (147 papers), Cardiovascular Function and Risk Factors (65 papers) and Cardiovascular Effects of Exercise (46 papers). Ethan J. Rowin is often cited by papers focused on Cardiomyopathy and Myosin Studies (147 papers), Cardiovascular Function and Risk Factors (65 papers) and Cardiovascular Effects of Exercise (46 papers). Ethan J. Rowin collaborates with scholars based in United States, Canada and Italy. Ethan J. Rowin's co-authors include Martin S. Maron, Barry J. Maron, Mark S. Link, Susan A. Casey, Ross Garberich, Raymond H. Chan, James E. Udelson, John R. Lesser, Hassan Rastegar and Tammy S. Haas and has published in prestigious journals such as Circulation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ethan J. Rowin

157 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and Evaluation of Hypertrophic Cardiomyopathy

2022 249 citations Barry J. Maron, Harry Rakowski et al. Journal of the American College of Cardiology profile →
Management of Hypertrophic Cardiomyopathy

2022 186 citations Barry J. Maron, Harry Rakowski et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ethan J. Rowin United States	41	4.8k	846	832	528	380	170	5.3k
Carey Kimmelstiel United States	26	2.3k 0.5×	817 1.0×	458 0.6×	358 0.7×	252 0.7×	74	3.1k
Elena Biagini Italy	35	3.8k 0.8×	881 1.0×	464 0.6×	968 1.8×	842 2.2×	170	4.8k
Camillo Autore Italy	33	2.6k 0.5×	468 0.6×	371 0.4×	573 1.1×	389 1.0×	147	3.4k
Sandro Betocchi Italy	31	4.5k 0.9×	640 0.8×	622 0.7×	359 0.7×	881 2.3×	96	4.9k
Maria Angela Losi Italy	34	4.1k 0.9×	522 0.6×	685 0.8×	404 0.8×	856 2.3×	139	4.8k
Stefano Nistri Italy	34	7.5k 1.6×	1.0k 1.2×	1.5k 1.8×	951 1.8×	982 2.6×	132	8.1k
Constantinos O’Mahony United Kingdom	23	2.2k 0.5×	417 0.5×	422 0.5×	277 0.5×	178 0.5×	62	2.7k
Marco Merlo Italy	34	3.5k 0.7×	758 0.9×	289 0.3×	834 1.6×	298 0.8×	228	4.4k
Seema Mital Canada	33	1.3k 0.3×	1.3k 1.5×	1.4k 1.7×	644 1.2×	127 0.3×	114	3.2k
John A. Jarcho United States	20	2.2k 0.4×	626 0.7×	380 0.5×	859 1.6×	63 0.2×	29	2.8k

Countries citing papers authored by Ethan J. Rowin

Since Specialization

Citations

This map shows the geographic impact of Ethan J. Rowin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan J. Rowin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan J. Rowin more than expected).

Fields of papers citing papers by Ethan J. Rowin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ethan J. Rowin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan J. Rowin. The network helps show where Ethan J. Rowin may publish in the future.

Co-authorship network of co-authors of Ethan J. Rowin

This figure shows the co-authorship network connecting the top 25 collaborators of Ethan J. Rowin. A scholar is included among the top collaborators of Ethan J. Rowin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ethan J. Rowin. Ethan J. Rowin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maron, Barry J., Ethan J. Rowin, Cristina Basso, et al.. (2025). Commentary: Sudden death in competitive student-athletes with hypertrophic cardiomyopathy at a crossroads: Critical views on liberalizing return-to-play eligibility. Heart Rhythm. 23(3). 688–695. 1 indexed citations

Sayed, Ahmed, Barry J. Maron, Ethan J. Rowin, & Martin S. Maron. (2025). Evidence of Declining Mortality Trends for Hypertrophic Cardiomyopathy in the United States and the Impact of the COVID‐19 Pandemic. Journal of the American Heart Association. 14(7). e037047–e037047.

Carrick, Richard & Ethan J. Rowin. (2024). Editorial commentary: Is it finally prime time for artificial intelligence to improve the care of patients with hypertrophic cardiomyopathy?. Trends in Cardiovascular Medicine. 35(2). 135–136.

Rowin, Ethan J., Raymond H. Chan, Michael T. Chin, et al.. (2024). Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy. Journal of the American Heart Association. 13(10). e033565–e033565. 10 indexed citations

Maron, Barry J., et al.. (2023). Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity. Heart Rhythm O2. 4(8). 506–516. 3 indexed citations

Fahmy, Ahmed S., Ethan J. Rowin, Raymond H. Chan, et al.. (2023). Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy. JACC. Cardiovascular imaging. 17(1). 16–27. 26 indexed citations

Wang, Rui‐Sheng, et al.. (2023). A novel patient–patient network medicine approach to refine hypertrophic cardiomyopathy subgrouping: implications for risk stratification. Cardiovascular Research. 119(3). e125–e127. 3 indexed citations

Maron, Barry J., N.A. Mark Estes, Ethan J. Rowin, Martin S. Maron, & Matthew R. Reynolds. (2023). Development of the Implantable Cardioverter-Defibrillator. Journal of the American College of Cardiology. 82(4). 353–373. 10 indexed citations

Maron, Bradley A., Rui‐Sheng Wang, Mercedes R. Carnethon, et al.. (2022). What Causes Hypertrophic Cardiomyopathy?. The American Journal of Cardiology. 179. 74–82. 29 indexed citations

10.

Abdelfattah, Omar, Matthew W. Martinez, Ahmed Sayed, et al.. (2022). Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JACC. Clinical electrophysiology. 8(11). 1417–1427. 18 indexed citations

11.

Maron, Bradley A., Rui‐Sheng Wang, Sergei Shevtsov, et al.. (2021). Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nature Communications. 12(1). 873–873. 63 indexed citations

12.

Maron, Martin S., Hassan Rastegar, Noreen Dolan, et al.. (2021). Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy. The American Journal of Cardiology. 163. 91–97. 19 indexed citations

13.

Carrick, Richard, Martin S. Maron, Arnon Adler, et al.. (2021). Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF Score. Circulation Arrhythmia and Electrophysiology. 14(6). e009796–e009796. 33 indexed citations

14.

Rowin, Ethan J., Barry J. Maron, Sophie Wells, et al.. (2021). Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy. The American Journal of Cardiology. 151. 86–92. 17 indexed citations

15.

Maron, Barry J., Martin S. Maron, Matthew J. Maurer, et al.. (2021). Cardiovascular Diseases That Have Emerged From the Darkness. Journal of the American Heart Association. 10(20). e021095–e021095. 6 indexed citations

16.

Habib, Manhal, Arnon Adler, Kate Hanneman, et al.. (2020). Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy. JACC. Cardiovascular imaging. 14(5). 947–958. 61 indexed citations

17.

Maron, Martin S., N.A. Mark Estes, Lori Lyn Price, et al.. (2019). Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy. The American Journal of Cardiology. 123(11). 1859–1862. 23 indexed citations

18.

Weinstock, Jonathan, et al.. (2014). Abstract 12223: ICD Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy Should Not be Abandoned. Circulation. 130. 1 indexed citations

19.

Rowin, Ethan J., Barry J. Maron, Iacopo Olivotto, et al.. (2013). Abstract 14979: Progressive Heart Failure is Uncommon in Patients With Nonobstructive Hypertrophic Cardiomyopathy. Circulation. 1 indexed citations

20.

Rowin, Ethan J., Martin S. Maron, Susan A. Casey, et al.. (2013). Abstract 13294: Evidence for Reduced Mortality in an Adult Cohort With Hypertrophic Cardiomyopathy. Circulation. 128. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact